P1029: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PELABRESIB (CPI-0610) IN COMBINATION WITH RUXOLITINIB VS RUXOLITINIB OR FEDRATINIB MONOTHERAPY IN PATIENTS WITH INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS
oleh: V. Gupta, J. Mascarenhas, M. Kremyanskaya, R. K. Rampal, M. Talpaz, J.-J. Kiladjian, A. Vannucchi, S. Verstovsek, G. Colak, D. Dey, C. Harrison
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-06-01 |
Deskripsi
No description available for this item.